Data / Form D filings / Vicapsys Life Sciences, Inc.
Vicapsys Life Sciences, Inc.: Form D filings
Vicapsys Life Sciences, Inc., a biotechnology company in Sawanee, GA, filed 5 Form D notices with the SEC between 2010 and 2023. The latest, on July 13, 2023, reports $330,000 sold of a $330,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7778 MCGINNIS FERRY RD. #270, Sawanee, GA, 30024
- Phone
- (972) 891-8033
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1468639
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | New notice | $330,000 | $330,000 | 1 | Jun 28, 2023 | sec.gov | |
| Feb 16, 2018 | New notice | $6,000,000 | $50,000 | $5,950,000 | 3 | Jan 19, 2018 | sec.gov |
| Jan 8, 2018 | New notice | Indefinite | $0 | 52 | Dec 22, 2017 | sec.gov | |
| May 25, 2010 | New notice | $1,500,000 | $470,000 | $1,030,000 | 17 | May 13, 2010 | sec.gov |
| May 24, 2010 | New notice | Indefinite | $0 | 4 | May 13, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Federico Pier | Executive Officer, Director | |
| Charlie Farrahar | Director | |
| Colleen Delaney | Director | |
| Dorothy Jordan | Director | |
| Jeffrey Wright | Executive Officer | |
| Richard Rosenblum | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vicapsys Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.